Features

LONDON (Capital Markets in Africa) — The U.K. is not a “post-racial” society but issues around race and racism are becoming less important as opportunities improve, a report commissioned by the government after the Black Lives Matter protests found. When the death of George Floyd last year prompted riots in the U.S., mirror protests took place around the U.K. against perceived police racism and the poorer life chances for ethnic minorities. The report by the Commission on…

LONDON (Capital Markets in Africa) — Prime Minister Boris Johnson sought to distance himself from a report into U.K racial inequalities that drew an angry backlash after suggesting the history of slavery could be taught from a different perspective than one of only pain and suffering. “There are some interesting things in it, I’m not going to say we agree with every word, but we’re going to be responding in due course,” Johnson told reporters…

NEW YORK (Capital Markets in Africa) — Invasive species have got a lot of damage to answer for over the last 50 years — roughly in the order of $1 trillion. Now, scientists are warning there’s even more to come. From ruining crop yields to wreaking havoc on human health, invasive species have been responsible for an array of global maladies over the past half century that have cost the world $1.28 trillion, researchers said…

LONDON (Capital Markets in Africa) – Tax year end in 2021 comes after a year like no other. Financially, every household will have been impacted differently. While some have experienced a loss in income, many will have decreased their outgoings and then either reduced personal debt or increased savings. In both scenarios, it is worth noting that the financial planning objectives might have changed. Longer-term plans put in place more than a year ago are…

LAGOS (Capital Markets in Africa) — Johnson & Johnson agreed to supply as many as 400 million Covid-19 vaccines to the African Union through the end of next year, delivering a boost to a continent trailing most of the world in the race to inoculate against the disease. The U.S. drugmaker can make available as many as 220 million doses of its single-shot candidate to the AU’s 55 member states starting in the third quarter…